Overview
As the global population ages, understanding how to support older adults in living independently and healthily in their own homes becomes paramount. "The Longevity Blueprint" is a thought-provoking event designed to explore the intersection of biological science, technological advancements, and community care solutions that facilitate effective aging in place.
This event will feature a diverse lineup of experts, including gerontologists, clinical innovators, healthcare providers and technological leaders, who will share insights on the latest research and trends in the longevity economy. Attendees will gain a comprehensive understanding of how biological factors influence aging and how they can be leveraged to create personalised health strategies, thereby enhancing quality of life for older adults.
Key topics of discussion include:
1. Biological Innovations: Exploration of cutting-edge research in genetics, regenerative medicine, and nutrition that contributes to healthier aging.
2. Technological Solutions: Examination of smart home technologies, telehealth systems, and wearable devices that empower older adults to manage their health and daily activities effectively while maintaining independence.
3. Community Engagement: Discussion on the role of community resources, support networks, and intergenerational programs in creating environments that foster social connections and collective well-being.
4. Holistic Strategies: Insights into how an integrated approach combining biology, technology, and community care can lead to sustainable solutions for aging in place that benefit individuals and society at large.
The event will feature a panel discussion and networking opportunities, allowing participants to engage with experts and peers in the field. By the end of the event, attendees will be equipped with actionable strategies and innovative ideas for developing a comprehensive longevity blueprint that prioritises the health and well-being of older adults in their communities.
Programme
2:00 PM – 2:30 PM: Registration
2:30 PM – 2:35 PM: Opening by SGInnovate
2:35 PM – 2:45 PM: Introduction by Teijin Pharma
2:45 PM – 3:30 PM: Panel Discussion + Q&A
3:30 PM – 4:00 PM: Networking
Schedule
Date: 19 Sep 2025, Friday
Time: 2:00 PM - 4:30 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: 32 Carpenter Street, 059911
Speakers
Moderator's Profile:
Mr. Jeffrey Chi, Ph.D, Founding Partner & Senior Consultant - Vickers Venture Partners, Founder & CEO - VantageX
Dr. Jeffrey Chi is a veteran in the venture capital industry and a strong advocate for the promotion of socially responsible investing & entrepreneurship. He is Founder & CEO of VantageX, a firm dedicated to helping high impact companies grow and succeed. Dr. Chi has expertise in life sciences, medical devices, healthcare, financial services (including fintech) and energy transition sectors. Previously, Dr. Chi co-founded Vickers Venture Partners where he served as its Vice Chairman for Asia. While he has stepped down from his executive postion, he remains a shareholder and a member of its investment committee. Dr Chi also contributes his expertise through various board and advisory roles. He currently serves of the board of Aardvark Therapeutics (NASDAQ: AARD), Jing Jin Electric (SH:688280, Electric Vehicle Drivetrains), Vivance (renal care company), Matchmove Pay (Fintech), QYH (Carbon credit development company) and others.
Speaker's Profile:
Prof. Andrea B. Maier, Oon Chiew Seng Professor in Medicine - National University of Singapore, Director - NUS Academy for Healthy Longevity
Andrea B. Maier (1978), a Fellow of the Royal Australasian College of Physicians (FRACP), graduated in Medicine (MD) 2003 from the University of Lübeck (Germany), was registered 2009 in The Netherlands as Specialist in Internal Medicine-Geriatrics and was appointed Full Professor of Gerontology at Vrije Universiteit Amsterdam (The Netherlands) in 2013. She was the head of Geriatrics at the Vrije Universiteit Medical Center from 2012 to 2016. From 2016 to early 2021 Professor Maier served as Divisional Director of Medicine and Community Care at the Royal Melbourne Hospital, Australia, and as Professor of Medicine and Aged Care at the University of Melbourne, Australia. She continued her career at the National University of Singapore as Director of the Centre for Healthy Longevity. Professor Maier’s research focuses on unraveling the mechanisms of ageing and age-related diseases to bring diagnostics and interventions to optimize health into clinical practice.
Speaker's Profile:
Dr. Philip Wong, Founder & CMO - WEB Biotechnology (Spyder ECG), Senior Consultant & Clinical Director - Raffles Heart Center
Dr. Wong is an Interventional Cardiologist with over 35 years of clinical experience. He had practiced for more than 30 years at the National Heart Center of Singapore and has performed more than 5000 coronary procedures. He moved to Raffles Hospital in 2021 and is currently the clinical director of Raffles Heart Center. His interests include Wireless Remote Cardiac Monitoring and Medical Data Management. He is the inventor of the Spyder Wireless ECG remote monitor, which currently provides long-distance real-time heart monitoring of patients across southeast asia. The system provides early detection of cardiac arrhythmias such as Atrial Fibrillation which increases risk of stroke in both young and aging patients.
Speaker's Profile:
Mr. Akihiro Maeda, Head of Scouting - Medtech, BD & License Dpt., Teijin Pharma Ltd
Akihiro (Aki) Maeda spent over 23 years in Teijin, currently a head of scouting medical devices for home-use in business development & license department, and leading strategic open innovation activities such as its own accelerator program, corporate venture arm, incubation program (including spin-out of internal project) and strategic alliances with external partners. Prior to this role, Aki was a resident for business development working at California office, US in Teijin for 5 years to seek for licensing-in opportunities with North American (USA & Canada) companies.
Partners
